{
  "author": {
    "name": "Kathryn Bucher  Laura Foggan A Xavier Baker",
    "webUrl": "/author/profile/kathryn-bucher--laura-foggan-a-xavier-baker/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 1,
    "social": [],
    "articles": [
      {
        "uri": "/2011/07/28/humana-v-glaxosmithkline-verdict-why-casualty-insurers-should-care/",
        "title": "Humana v. GlaxoSmithKline Verdict: Why Casualty Insurers Should Care",
        "byline": "Kathryn Bucher , Laura Foggan, A. Xavier Baker",
        "kicker": "Commentary",
        "prettyDate": "July 28, 2011",
        "timeToRead": "7 minute",
        "image": {
          "uri": "",
          "width": "",
          "height": ""
        },
        "authors": [
          {
            "webUrl": "/author/profile/kathryn-bucher--laura-foggan-a-xavier-baker/",
            "name": "Kathryn Bucher , Laura Foggan, A. Xavier Baker"
          }
        ],
        "kickerNode": [
          {
            "uri": "/commentary/",
            "sectionName": "Commentary"
          }
        ],
        "summary": "Last month, a U.S. district court joined a growing number of federal courts in rejecting a Medicare Advantage plan’s assertion of a federal private right of action against casualty insurers under the Medicare Secondary Payer laws.",
        "body": null
      }
    ]
  }
}